LAUSR

Objective This study provides an insight of the impact of the COVID-19 pandemic on the breast surgical field in our setup. We will summarize the safety measures we adapted over the time span of COVID-19 pandemic and also decision making in prioritizing patients with respect to tumor biology, stage and phase of treatment and effects of COVID-19 on post op patients in terms of morbidity and mortality. In addition we will discuss new aspects of patient-healthcare worker communication. Materials and Methods A retrospective study at a single institution was reviewed from April 2020 to June 2020. Patients operated for breast cancer only included in this study to estimate their chances of getting COVID-19 infection or if operated after contracting COVID -19 infection what is their probability to develop pulmonary complications in 30 days period post op.